Tye-1002

N/A

Report date: 2024/11/21 15:14:55

Base Information

Drug NameTye-1002
Drug Alias NameTye-1002
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionSomatostatin receptor 2 modulators
TargetsSomatostatin receptor 2
Therapy Area/IndicationsSmall Cell Lung CarcinomaNasopharyngeal CarcinomaNeuroendocrine Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenzhen Tyercan Bio-pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Tyercan Bio-pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaNasopharyngeal CarcinomaNeuroendocrine Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A